Using automated testing tools


Automated testing tools are useful in assisting in the identification of video accessibility issues and errors of a website.

These tools are able to perform ‘machine-operable’ testing only, and should be used as a companion alongside human site review and testing.

The following testing tool information is provided as a guide only and is not an exhaustive list.

Recommended tools

The following testing tools are recommended as the most suitable, based on volume of content being tested:
ToolTesting volumeType of tool
OzARTLarge section of pages or entire website.Commercial product – online reporting tool producing video location information, list of links to videos, list of links to transcripts, reduces time spent manually searching for single videos.
Photosensitive Epilepsy Analysis Tool (PEAT)Singular videosFree, downloadable resource to analyse videos on seizure risk from flashing content.
NB: In some instances, only one tool may be suitable regardless of the volume of pages to be tested. In addition, if no tool is suitable, a manual site review will be required.


OzART is a commercial online application developed by AccessibilityOz to evaluate the accessibility of web sites and documents. OzART delivers specific accessibility reports that are used to direct and inform accessibility audit testing and to facilitate the creation of a tailored set of fix lists used for error correction.

OzART video reports:

  • List of links to all embedded objects (eg. Flash)
    • Allows review of embedded objects which will mostly be videos
    • Facilitates identification of videos on the site
  • List of links to pages containing the word transcript or transcripts
    • Facilitates identification of transcripts on the site.

Photosensitive Epilepsy Analysis Tool (PEAT)

PEAT is a free, downloadable application to assist developers in identifying content on their site that may induce seizures in people with photosensitive seizure disorders.

PEAT video reports:

  • Analyse singular videos
    • Determines seizure risks and places where the content could be modified to remove the high risk spots.